Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ORITAVANCIN DIPHOSPHATE: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

39.2%
Female
60.8%
Male

Age Information

The average age of patients reporting adverse events with ORITAVANCIN DIPHOSPHATE is 58.5 years.

Geographic Distribution

The majority of adverse event reports for ORITAVANCIN DIPHOSPHATE originate from US.

Report Summary & Outcomes

276
Total Reports
276
As Primary/Secondary Suspect
4
Deaths Reported
27
Hospitalizations
5
Life-Threatening

Reporting Timeline

First adverse event report: 20210817. Most recent report: 20250606. View full timeline →

More About ORITAVANCIN DIPHOSPHATE

ORITAVANCIN DIPHOSPHATE Full Profile Reports by Year Drug Interactions